97-430. Manufacturer of Controlled Substances; Notice of Application

[Federal Register Volume 62, Number 5 (Wednesday, January 8, 1997)]
[Notices]
[Page 1134]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-430]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE
Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.43(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on November 15, 1996, Orpharm, 
Inc., 728 West 19th Street, Houston, Texas 77008, made application by 
renewal to the Drug Enforcement Administration (DEA) for registration 
as a bulk manufacturer of the basis classes of controlled substances 
listed below:

------------------------------------------------------------------------
                    Drug                               Schedule         
------------------------------------------------------------------------
Methadone (9250)............................  II                        
Methadone-intermediate (9254)...............  II                        
Levo-alphacetylmethadol (LAAM) (9648).......  II                        
------------------------------------------------------------------------

    The firm plans to manufacture methadone and methadone-intermediate 
for the production of LAAM.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the above application.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, D.C. 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than March 10, 1997.

    Dated: December 17, 1996.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 97-430 Filed 1-17-97; 8:45 am]
BILLING CODE 4410-09-M